Medical management of unruptured interstitial pregnancy with mifepristone and methotrexate

Authors

  • Usha Karki Department of Obstetrics and Gynaecology, Kathmandu Medical College Teaching Hospital, Kathmandu
  • Rachana Saha Department of Obstetrics and Gynaecology, Kathmandu Medical College Teaching Hospital, Kathmandu

DOI:

https://doi.org/10.3126/jkmc.v4i1.15028

Keywords:

Ectopic pregnancy, Fertility rate, Interstitial Pregnancy, Medical management

Abstract

Ectopic pregnancy is a serious complication of pregnancy in which embryo gets implanted any where other than the uterine cavity. In interstitial pregnancy, the pregnancy is located in that part of the fallopian tube that penetrates the muscular layer of the uterus. Overall incidence of ectopic pregnancy is one to two percent among which the incidence of interstitial pregnancy is only two percent. Interstitial pregnancy being the hazardous type requires immediate management. Though surgical treatment is the management of choice, its association with decreased fertility rate and increased rate of uterine rupture in future pregnancy cannot be ignored. We hereby report of medical management of interstitial ectopic pregnancy with single oral dose of Mifepristone 200mg along with single dose of Methotrexate 50miligram intramuscularly.

Journal of Kathmandu Medical College, Vol. 4(1) 2015, 34-36

Downloads

Download data is not yet available.
Abstract
694
PDF
650

Author Biographies

Usha Karki, Department of Obstetrics and Gynaecology, Kathmandu Medical College Teaching Hospital, Kathmandu

MD Resident

Rachana Saha, Department of Obstetrics and Gynaecology, Kathmandu Medical College Teaching Hospital, Kathmandu

Professor

Downloads

Published

2016-05-31

How to Cite

Karki, U., & Saha, R. (2016). Medical management of unruptured interstitial pregnancy with mifepristone and methotrexate. Journal of Kathmandu Medical College, 4(1), 34–36. https://doi.org/10.3126/jkmc.v4i1.15028

Issue

Section

Case Reports

Most read articles by the same author(s)